Latest California Healthline Stories
KHN’s ‘What The Health?’: Gun Violence And The Politics Of Public Health
The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
Recomendación sobre la vacuna contra el VPH para adultos puede generar confusión
El virus del papiloma humano es la infección de transmisión sexual más común en los Estados Unidos; casi todas las personas sexualmente activas lo contraerán en algún momento.
Price Of Snakebite Drug Is Sky High, But New Competitor Unlikely To Lower Costs
The drug CroFab, which has been on the market since 2000, now faces competition from a drug called Anavip. But both are expensive.
Federal Experts’ Advice On HPV Vaccine Could Leave Adults Confused
A federal advisory panel says people between ages 27 and 45 may benefit from the vaccine to fight the human papillomavirus. But some public health advocates worry that the advice doesn’t provide doctors and patients clear guidance about who in this large age group are good candidates for the vaccine.
Doctors Argue Plans To Remedy Surprise Medical Bills Will ‘Shred’ The Safety Net
A case of questionable logic.
Watch: What Happened To That $500K Dialysis Bill
After journalists investigate, Fresenius, one of the largest dialysis providers in the U.S., has agreed to waive a half-million-dollar bill. Sovereign Valentine, from Plains, Mont., said it’s a “huge relief.”
Estrellas del deporte popularizan terapias con células madre que no están probadas
Médicos están preocupados por el mensaje equivocado que se está enviando sobre estos tratamientos que, dicen, no están probados y realmente no aceleran los procesos de recuperación.
Drugmakers Now ‘Masters’ At Rolling Out Their Own Generics To Stifle Competition
Known as “authorized generics,” in-house spinoffs of brand-name drugs quietly undermine the competition.
Superstar Athletes Popularize Unproven Stem Cell Procedures
Treatments for baseball pitcher Max Scherzer and other pros may mislead fans about costly, controversial, unapproved stem cell shots.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.